Cell-free formation of protease-resistant prion protein

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Nature

• Publication date

  1994-08-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/370471A0PMID 7913989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diversity in the neuropathology of scrapie-like diseases in animals.

  1993cited by this paper
• Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing.

  1993cited by this paper
• Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• A kinetic model for amyloid formation in the prion diseases: importance of seeding.

  1993cited by this paper
• Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells

  1993cited by this paper
• Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells.

  1993cited by this paper
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

  1993cited by this paper
• N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state

  1991cited by this paper
• Molecular biology of prion diseases

  1991cited by this paper
• The scrapie agent: "a virus by any other name".

  1991cited by this paper
• The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist.

  1991cited by this paper
• A 'unified theory' of prion propagation

  1991cited by this paper
• Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy.

  1991cited by this paper
• The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive.

  1991cited by this paper
• Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells

  1990cited by this paper
• The search for scrapie agent nucleic acid.

  1990cited by this paper
• Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.

  1990cited by this paper
• Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation.

  1990cited by this paper
• Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells

  1989cited by this paper
• Novel infectious agents and the central nervous system

  1988cited by this paper
• Separation and properties of cellular and scrapie prion proteins.

  1986cited by this paper
• The major polypeptide of scrapie‐associated fibrils (SAF) has the same size, charge distribution and N‐terminal protein sequence as predicted for the normal brain protein (PrP).

  1986cited by this paper
• Purification and structural studies of a major scrapie prion protein.

  1984cited by this paper
• Scrapie infectivity, fibrils and low molecular weight protein

  1983cited by this paper
• Identification of a protein that purifies with the scrapie prion.

  1982cited by this paper
• Self-replication and scrapie.

  1967cited by this paper
• Nature of the Scrapie Agent: Self-replication and Scrapie

  1967cited by this paper
• The possible nature of the transmissible agent of scrapie

  1967cited by this paper

• Alpha-synuclein seeding amplification assays in Lewy body dementia: a brief review

  2025cites this paper
• Characterization of the Long-distance Dispersal Kernel of White-Tailed Deer and Evaluating its Impact on Chronic Wasting Disease Spread in Wisconsin

  2025cites this paper
• Tracking Prions by RT-QuIC: An Update.

  2025cites this paper
• Prions and protein aggregates as pathogens, self-propagating structures, biomarkers, and therapeutic targets

  2025cites this paper
• The infectious potential of protein misfolding: insights from cross-over studies of prion diseases and common neurodegenerative disorders.

  2025cites this paper
• Tau biomarkers for neurodegenerative diseases: Current state and perspectives.

  2025cites this paper
• Soluble N-terminal region of prion protein causes rapid neurodegeneration in prion disease

  2025cites this paper
• Detection of chronic wasting disease prions in the farm soil of the Republic of Korea

  2025cites this paper
• A comprehensive phylogeny of mammalian PRNP gene reveals no influence of prion misfolding propensity on the evolution of this gene

  2025cites this paper
• Maladies à prions ou encéphalopathies spongiformes transmissibles

  2025cites this paper
• Anti‐Prion Systems in Saccharomyces cerevisiae

  2025cites this paper
• Development of High‐Throughput Genomic Resources to Inform White‐Tailed Deer Population and Disease Management

  2025cites this paper
• Navigating the Neurobiology of Parkinson’s: The Impact and Potential of α-Synuclein

  2024cites this paper
• The Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome

  2024cites this paper
• Chronic Wasting Disease: State of the Science

  2024cites this paper
• Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases

  2024cites this paper
• A Protein Misfolding Shaking Amplification-based method for the spontaneous generation of hundreds of bona fide prions

  2024cites this paper
• (Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation

  2023cites this paper
• Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation

  2023cites this paper
• Conservation of vCJD Strain Properties After Extraction and In Vitro Propagation of PrPSc from Archived Formalin-Fixed Brain and Appendix Tissues Using Highly Sensitive Protein Misfolding Cyclic Amplification

  2023cites this paper
• Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid

  2023cites this paper
• The Zoonotic Potential of Chronic Wasting Disease—A Review

  2023cites this paper
• Full-length prion protein incorporated into prion aggregates is a marker for prion strain specific destabilization of aggregate structure following cellular uptake.

  2023cites this paper
• The smallest infectious substructure encoding the prion strain structural determinant revealed by spontaneous dissociation of misfolded prion protein assemblies

  2023cites this paper
• Recombinant Mammalian Prions: The “Correctly” Misfolded Prion Protein Conformers

  2022cites this paper
• Phase separation of the mammalian prion protein: Physiological and pathological perspectives

  2022cites this paper
• Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases.

  2022cites this paper
• The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases

  2022cites this paper
• Recent Advances in Prion Inactivation by Plasma Sterilizer

  2022cites this paper
• PMCA for ultrasensitive detection of prions and to study disease biology

  2022cites this paper
• The first non-prion pathogen identified: neurotropic influenza virus

  2022cites this paper
• Structural biology of ex vivo mammalian prions

  2022cites this paper
• Seed amplification and RT-QuIC assays to investigate protein seed structures and strains

  2022cites this paper
• Prion strains: shining new light on old concepts

  2022cites this paper
• RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein

  2022cites this paper
• RT-QuIC as ultrasensitive method for prion detection

  2022cites this paper
• Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation.

  2021cites this paper
• Laboratory Identification of Prion Infections

  2021cites this paper
• Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion

  2021cites this paper
• High-resolution structure and strain comparison of infectious mammalian prions.

  2021cites this paper
• Structure of an infectious mammalian prion

  2021cites this paper
• Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids

  2021cites this paper
• Human cerebral organoids as a therapeutic drug screening model for Creutzfeldt–Jakob disease

  2021cites this paper
• The G127V variant of the prion protein interferes with dimer formation in vitro but not in cellulo

  2021cites this paper
• Parkinson’s Disease: A Prionopathy?

  2021cites this paper
• From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins

  2020cites this paper
• Cofactor molecules: Essential partners for infectious prions.

  2020cites this paper
• The role of prion strain diversity in the development of successful therapeutic treatments.

  2020cites this paper
• Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In Vitro

  2020cites this paper
• Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation

  2020cites this paper
• Pathogens

  2020cites this paper
• Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids

  2020cites this paper
• RNA as the stone guest of protein aggregation

  2020cites this paper
• Cryo-EM structure of a human prion fibril with a hydrophobic, protease-resistant core

  2020cites this paper
• Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases

  2020cites this paper
• Phenotypic diversity in ALS and the role of poly-conformational protein misfolding

  2020cites this paper
• Proteopathic Seed Amplification Assays for Neurodegenerative Disorders.

  2020cites this paper
• Microtubule-Associated Protein Tau

  2020cites this paper
• A Novel, Reliable and Highly Versatile Method to Evaluate Different Prion Decontamination Procedures

  2020cites this paper
• In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.

  2019cites this paper
• In vitro Modeling of Prion Strain Tropism

  2019cites this paper
• The gut-brain axis in the pathogenesis of Parkinson’s disease

  2019cites this paper
• More than cell wall hydrolysis: orchestration of cellular dynamics for organ separation.

  2019cites this paper
• Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications

  2019cites this paper
• Breakthroughs in antemortem diagnosis of neurodegenerative diseases

  2019cites this paper
• COMITE ORGANIZADOR

  2019cites this paper
• Synthesis and in silico and in vitro evaluation of trimethoxy-benzamides designed as anti-prion derivatives

  2019cites this paper
• Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons

  2019cites this paper
• [Elucidation of the Molecular Basis of Abnormal Prion Protein (PrP) Formation in a Cell-Free System Using Baculovirus and Insect Cell-derived Recombinant PrP].

  2019cites this paper
• Transmissible Spongiform Encephalopathies

  2019cites this paper
• Early and Pre-Clinical Detection of Prion Seeding Activity in Cerebrospinal Fluid of Goats using Real-Time Quaking-Induced Conversion Assay

  2019cites this paper
• Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes

  2019cites this paper
• Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates

  2019cites this paper
• Review: PrP 106‐126 – 25 years after

  2019cites this paper
• Experimental models to study prion disease pathogenesis and identify potential therapeutic compounds.

  2019cites this paper
• The prion-like properties of assembled human alpha-synuclein

  2018cites this paper
• Interrogating the Dimerization Interface of the Prion Protein Via Site-Specific Mutations to p-Benzoyl-L-Phenylalanine.

  2018cites this paper
• Desarrollo de un nuevo sistema de cribado masivo basado en la propagación in vitro de priones recombinantes infecciosos para la detección de compuestos con actividad anti-priónica.

  2018influential citation
• Role of the Disulfide Bond in Prion Protein Amyloid Formation: A Thermodynamic and Kinetic Analysis.

  2018cites this paper
• The cellular and pathologic prion protein.

  2018cites this paper
• Prion-like mechanisms in amyotrophic lateral sclerosis.

  2018cites this paper
• Organization of GPI-anchored proteins at the cell surface and its physiopathological relevance

  2018cites this paper
• Prions activate a p38 MAPK synaptotoxic signaling pathway

  2018cites this paper
• The zoonotic potential of animal prion diseases.

  2018cites this paper
• Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice

  2017cites this paper
• Prion disease: experimental models and reality

  2017cites this paper
• Amplification of Misfolded Prion Proteins in Blood and Cerebrospinal Fluid for Detection of Creutzfeldt-Jakob Disease.

  2017cites this paper
• Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

  2017cites this paper
• Understanding the Effect of Disease-Related Mutations on Human Prion Protein Structure: Insights From NMR Spectroscopy.

  2017cites this paper
• Protein-Based Inheritance: Epigenetics beyond the Chromosome.

  2017cites this paper
• Chronic Wasting Disease: Evolution of Diagnostic Testing for a Naturally Occurring Prion Disease

  2017cites this paper
• Prion Diagnosis: Application of Real-Time Quaking-Induced Conversion

  2017cites this paper
• Neuropathology and molecular biology of iatrogenic Creutzfeldt-Jakob disease in UK human growth hormone recipients

  2017cites this paper
• Real-Time Quaking-Induced Conversion for Diagnosis of Prion Disease.

  2017cites this paper
• Bioassays and Inactivation of Prions.

  2017cites this paper
• Amplified Detection of Prions and Other Amyloids by RT-QuIC in Diagnostics and the Evaluation of Therapeutics and Disinfectants.

  2017cites this paper
• Prion Diseases.

  2017cites this paper
• Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates

  2017cites this paper
• Endocytic Vesicle Rupture in the Pathogenesis and Propagation of Neurodegenerative Proteinopathies

  2017cites this paper
• A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location

  2017cites this paper